期刊文献+

脑利钠肽对心力衰竭远期心脏事件的预测价值 被引量:7

Long prognostic value of B-natriuretic peptide on admission in patients with chronic heart failure
原文传递
导出
摘要 目的:研究血浆脑利钠肽(BNP)对慢性心力衰竭(心衰)患者远期心脏事件的预测价值。方法:入选134例心衰患者,双抗体夹心免疫荧光法测定血浆BNP浓度,记录发生的心脏事件。结果:134例中随访资料完整130例,随访时间平均(708±220)d。130例中发生心脏事件者44例(心脏事件组),未发生心脏事件者86例(非心脏事件组),心脏事件组左室舒张末期内径、心胸比率、BNP均较非心脏事件组显著升高(均P<0.01)。多元logistic回归分析显示,BNP为心衰患者远期心脏事件独立的预测因子。BNP预测心源性死亡ROC曲线下面积为0.846。BNP取值702.5 ng/L预测心源性死亡的敏感度和特异度达最高。血浆BNP≤702.5 ng/L患者生存率高于BNP>702.5 ng/L者(P<0.05)。结论:BNP是影响慢性心衰患者远期心脏事件的独立预测因素。 Objective:To evaluate the long prognostic value of plasma B natriuretic peptide (BNP) on predicting cardiovascular events after hospital discharge in patients with chronic heart failure (CHF). Method: Patients with CHF (n= 134) were included in this study. Plasma BNP level was obtained by a rapid immunofluorescence assay in all patients. Left ventricular end diastolic diameter (LVEDD) and cardiothoracic ratio (CRT) were performed within 24 h before or after catheterization. All CHF patients were received conventional therapy and the rates of cardiac death and rehospitalization were used as end points during 3-year follow up. Result: ①LVEDD, CRT and BNP were increased in patients with cardiac events compared with patients without cardiac events (P〈0. 01). ②Multivariant logistic analysis showed that the independent factors for cardiac events in patients with CHF was BNP (OR= 1. 005,95 %CI 1. 002-1. 007). ③The areas under the receiver operating curve (ROC), when BNP was used to predict cardiac death of C HF, was 0. 846 (95 % CI 0.771-0. 922). For predicting cardiac death in patients with CHF, BNP cutoff point of 720.5 ng/L had a sensitivity of 76.5%, a specificity of 75.2%. ④The survival rate of patients in group of BNP≤702. 5 ng/L was much higher than that in group of BNP〉702. 5 ng/L (0R=4. 383, 95% CI 1. 407-13. 650). Kaplan-Meier cumulative survival analysis supported the above results. Conclusion: Plasma BNP is an independent predictor for prognosis of patients with CHF.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第2期112-114,共3页 Journal of Clinical Cardiology
关键词 心力衰竭 充血性 利钠肽 预后 heart failure, congestive natriuretic peptide, brains prognosis
  • 相关文献

参考文献9

  • 1MACINTYRE L, CAPEWELL S, STEWARD S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995[J]. Circulation, 2000, 102: 1126-1131.
  • 2GROENNING B A, NILSSON J C, SONDERGARD L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations[J]. Eur J Heart Fail, 2001, 3:699-708.
  • 3BETTENCOURT P, FERREIRA A, DIAS P. Predictors of prognosis in patients with stable mild to moderate heart failure[J]. J Card Fail, 2000, 6:306-313
  • 4胡咏梅,赵思勤,李秋,聂晓莉,吴涛,刘小蓉,王勉,张文勇.慢性心力衰竭患者血浆脑钠肽和内皮素-1水平与血流动力学的相关性[J].临床心血管病杂志,2006,22(11):672-674. 被引量:27
  • 5KAZANEGRA R, CHENG V, GARCIA A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for deeom pensated heart failure: A pilot study[J]. J Card Fail, 2001,7:21-29.
  • 6CHENG V, KAZANAGRA R, GARCIA A, et al. A rapid bedside test for B-type peptides predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study[J]. J Am Coll Cardiol, 2001,37:386-391.
  • 7ALEHAGEN U, LINDSTEDT G, LEVIN LA, et al. Risk of cardiovascular death in elderly patients with possible heart /allure. Btype natriuretic peptides (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6- year follow-up of a primary care population[J]. Inter J Cardiol, 2005,100:125-133.
  • 8McDONAGH T, CUNNINGHAM A D, MORRISON C E, et al. Left ventricular dysfunction, natriuretic peptide, and mortality in an urban population [J]. Heart, 2001,86:21-26.
  • 9YU C M, SANDERSON J E. Plasma brain batriuretic peptide: an independent predictor of cardiovascular mortality in acute heart failure[J]. Eur J Heart, 1999, 1: 59-65.

二级参考文献10

  • 1GROENNING B A, NILSSON J C, SONDERGAARD L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [J].Eur J Heart Fail, 2001,3:699-708.
  • 2BARTON M, KIOWSKI W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease[J]. Curr Hypertens Rep, 2001,3:322- 330.
  • 3BOULANGER C M. Secondary endothelial dysfunction: hypertension and heart failure[J]. J Cell Cardiol, 1999,31: 39-49.
  • 4YAMAMOTO K, BURNETT J, BERMUDEZ E A, et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction[J]. J Card Fail, 2000,6:194-200.
  • 5KAZANEGRA R, CHENG V, GARCIA A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for decompensated heart failure: A pilot study[J]. J Card Fail, 2001,7:21-29.
  • 6MULDER P, BOUJEDAINI, H, RICHARD V, et al. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy [J]. Circulation, 2002,27,106: 1159-1164.
  • 7LUCHNER A, STEVENS TL, BORGESON DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure[J]. Am J Physiol, 1998,274:1684-1689.
  • 8SUZUKI T, YAMAZAKI Y, YAZAKI Y. The role of the natriuretic peptide in the cardiovascular system [J]. Cardiovasc Res, 2001,51:489-494.
  • 9SAM F, COLUCCI WS. Role of endothelin-1 in myocardial failure[J]. Proc Assoc Am Physicians, 1999, 111: 417-422.
  • 10DUCHMAN S M, THOHAN V, KALRAD, et al. Endothelin-1: a new target of therapeutic intervention for the treatment of heart failure[J]. Curr Opin Cardiol, 2000,15:136-140.

共引文献26

同被引文献54

  • 1史晓敏,林箐,徐国宾,宋以信,夏铁安.血清N末端B型钠尿肽原在心功能评价及慢性充血性心力衰竭诊断中的初步应用[J].中华检验医学杂志,2005,28(1):37-41. 被引量:77
  • 2李崇剑,徐耕,傅国胜,蔡思宇,单江.颈动脉粥样硬化超声标识及血清C-反应蛋白与冠心病的关系[J].中华心血管病杂志,2005,33(9):853-853. 被引量:10
  • 3汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 4邵亮,李南方.脑利钠肽在临床心血管疾病中的应用进展[J].临床心血管病杂志,2007,23(3):164-166. 被引量:15
  • 5O'Loughlin C,Murphy N F,Conlon C,et al. Quality of life predicts outcome in a heart failure disease management program.Int J Cardiol,2010,139(1): 60-67.
  • 6Rodriguez-Artalejo F,Guallar-Castillon P, Pascual CR,et al.Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med,2005,165(11):1274-1279.
  • 7Apple FS,Smith SW, Pearce LA,et al.Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.Clin Chem,2008,54(4):723-728.
  • 8Gheorghiade M,Pang PS.Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coil Cardiol,2009,53 (25):2349-2352.
  • 9Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during a randomized,double-blind,placebo-controlled trial of pimobendan.Ameriean Heart Journal,1992,124:1017- 1025.
  • 10Moser DK,Yamokoski L,Sun JL,et al. Improvement in Health-related Quality of Life After Hospitalization Predicts Event-free Survival in Patients With Advanced Heart Failure.Journal of Cardiac Failure,2009,15(9):763-769.

引证文献7

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部